Cargando…

NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma

BACKGROUND: Na(+)/H(+) exchanger (NHE) maintains the alkaline pH of epithelial cells working at the cellular membrane and exchanging H(+)/Na(+) ions. In renal tubular epithelial cells, the reabsorption of NaCl is implemented by NHE3 isoform, which is regulated by NHE regulatory factor-1 (NHERF1). No...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksionau, Aliaksandr, Silva, Roberto A., Hartman, Brandon, Flowers, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481195/
https://www.ncbi.nlm.nih.gov/pubmed/37680228
http://dx.doi.org/10.21037/tau-23-101
_version_ 1785101922776121344
author Aksionau, Aliaksandr
Silva, Roberto A.
Hartman, Brandon
Flowers, Ashley
author_facet Aksionau, Aliaksandr
Silva, Roberto A.
Hartman, Brandon
Flowers, Ashley
author_sort Aksionau, Aliaksandr
collection PubMed
description BACKGROUND: Na(+)/H(+) exchanger (NHE) maintains the alkaline pH of epithelial cells working at the cellular membrane and exchanging H(+)/Na(+) ions. In renal tubular epithelial cells, the reabsorption of NaCl is implemented by NHE3 isoform, which is regulated by NHE regulatory factor-1 (NHERF1). Normally situated at the apical zones of proximal tubular cells, NHERF1 participates in cytoskeletal reorganization and signal transduction facilitating structural stability and ion exchange. Based on an extensive search in English literature, NHERF1/EBP50 immunoexpression has been studied in breast, colon, and other tumors with only one study on 21 cases of renal cell carcinomas (RCC). METHODS: Using NHERF1/EBP50 immunohistochemistry (IHC) on 64 (82%) RCCs (34 clear cells, 21 papillary and 9 chromophobe types) and 14 (18%) oncocytomas, we evaluated and scored NHERF1/EBP50 immunoexpression depending on the World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grading system followed by ultrastructural identification of microlumen-like structures (MLS) in clear cell renal cell carcinomas (ccRCC). RESULTS: Staining patterns varied throughout the tumors and within individual tumors. Only ccRCC showed unique MLS within the cytoplasm of tumor cells. All neoplasia-transformed tubular cells, regardless of the tumor grade and stage, had altered immunoexpression of NHERF1/EBP50 ranging from complete absence to aberrant expression in the luminal cell membrane, nuclear or cytoplasmic localizations. CONCLUSIONS: Only ccRCC showed unique dot-like condensations of immunostaining/MLS at membranous, submembranous, and paranuclear localizations. The latter two localizations were mainly observed in the combined WHO/ISUP grade 1 and 2 group compared to the combined group of grade 3 and 4 tumor samples (P=0.0146 and P<0.0001, respectively). Ultrastructurally, the MLS were identified as thick microvilli trapped by a single-layer membrane, displaced into the cytoplasm and ranging from 400 nm to 3.5 µm. These significant ultrastructural reorganizations may contribute to tumor progression, metastasis, and drug resistance.
format Online
Article
Text
id pubmed-10481195
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104811952023-09-07 NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma Aksionau, Aliaksandr Silva, Roberto A. Hartman, Brandon Flowers, Ashley Transl Androl Urol Original Article BACKGROUND: Na(+)/H(+) exchanger (NHE) maintains the alkaline pH of epithelial cells working at the cellular membrane and exchanging H(+)/Na(+) ions. In renal tubular epithelial cells, the reabsorption of NaCl is implemented by NHE3 isoform, which is regulated by NHE regulatory factor-1 (NHERF1). Normally situated at the apical zones of proximal tubular cells, NHERF1 participates in cytoskeletal reorganization and signal transduction facilitating structural stability and ion exchange. Based on an extensive search in English literature, NHERF1/EBP50 immunoexpression has been studied in breast, colon, and other tumors with only one study on 21 cases of renal cell carcinomas (RCC). METHODS: Using NHERF1/EBP50 immunohistochemistry (IHC) on 64 (82%) RCCs (34 clear cells, 21 papillary and 9 chromophobe types) and 14 (18%) oncocytomas, we evaluated and scored NHERF1/EBP50 immunoexpression depending on the World Health Organization (WHO)/International Society of Urological Pathology (ISUP) grading system followed by ultrastructural identification of microlumen-like structures (MLS) in clear cell renal cell carcinomas (ccRCC). RESULTS: Staining patterns varied throughout the tumors and within individual tumors. Only ccRCC showed unique MLS within the cytoplasm of tumor cells. All neoplasia-transformed tubular cells, regardless of the tumor grade and stage, had altered immunoexpression of NHERF1/EBP50 ranging from complete absence to aberrant expression in the luminal cell membrane, nuclear or cytoplasmic localizations. CONCLUSIONS: Only ccRCC showed unique dot-like condensations of immunostaining/MLS at membranous, submembranous, and paranuclear localizations. The latter two localizations were mainly observed in the combined WHO/ISUP grade 1 and 2 group compared to the combined group of grade 3 and 4 tumor samples (P=0.0146 and P<0.0001, respectively). Ultrastructurally, the MLS were identified as thick microvilli trapped by a single-layer membrane, displaced into the cytoplasm and ranging from 400 nm to 3.5 µm. These significant ultrastructural reorganizations may contribute to tumor progression, metastasis, and drug resistance. AME Publishing Company 2023-08-14 2023-08-31 /pmc/articles/PMC10481195/ /pubmed/37680228 http://dx.doi.org/10.21037/tau-23-101 Text en 2023 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Aksionau, Aliaksandr
Silva, Roberto A.
Hartman, Brandon
Flowers, Ashley
NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma
title NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma
title_full NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma
title_fullStr NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma
title_full_unstemmed NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma
title_short NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma
title_sort nherf1/ebp50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481195/
https://www.ncbi.nlm.nih.gov/pubmed/37680228
http://dx.doi.org/10.21037/tau-23-101
work_keys_str_mv AT aksionaualiaksandr nherf1ebp50immunoexpressioninrenalcellcarcinomasandoncocytomaswithultrastructuralanalysisofclearcellrenalcellcarcinoma
AT silvarobertoa nherf1ebp50immunoexpressioninrenalcellcarcinomasandoncocytomaswithultrastructuralanalysisofclearcellrenalcellcarcinoma
AT hartmanbrandon nherf1ebp50immunoexpressioninrenalcellcarcinomasandoncocytomaswithultrastructuralanalysisofclearcellrenalcellcarcinoma
AT flowersashley nherf1ebp50immunoexpressioninrenalcellcarcinomasandoncocytomaswithultrastructuralanalysisofclearcellrenalcellcarcinoma